X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
index medicus (20) 20
breast cancer (19) 19
female (19) 19
oncology (15) 15
breast neoplasms - drug therapy (13) 13
breast neoplasms - metabolism (10) 10
article (9) 9
breast neoplasms - pathology (9) 9
cell line, tumor (8) 8
receptor, erbb-2 - metabolism (8) 8
analysis (7) 7
cdk4/6 inhibitors (7) 7
endocrine therapy (7) 7
middle aged (7) 7
adult (6) 6
breast neoplasms - genetics (6) 6
cancer (6) 6
chemotherapy (6) 6
expression (6) 6
receptors, estrogen - metabolism (6) 6
tamoxifen (6) 6
treatment outcome (6) 6
aged (5) 5
animals (5) 5
antineoplastic agents, hormonal - therapeutic use (5) 5
estrogen-receptor (5) 5
gene expression (5) 5
immunohistochemistry (5) 5
medicine & public health (5) 5
prognosis (5) 5
resistance (5) 5
1st-line treatment (4) 4
6 inhibitors (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomarkers (4) 4
breast neoplasms - mortality (4) 4
cdk4 (4) 4
cells (4) 4
estrogen (4) 4
estrogen receptor (4) 4
gene expression regulation, neoplastic (4) 4
growth-factor receptor (4) 4
metastasis (4) 4
mice (4) 4
survival analysis (4) 4
tamoxifen - administration & dosage (4) 4
tamoxifen resistance (4) 4
care and treatment (3) 3
cell biology (3) 3
dependent kinase 4/6 (3) 3
differentiation (3) 3
double-blind (3) 3
drug resistance (3) 3
fulvestrant (3) 3
gene-expression (3) 3
metastatic breast cancer (3) 3
neoadjuvant therapy (3) 3
neoplasm metastasis (3) 3
neoplasm staging (3) 3
palbociclib (3) 3
pathology (3) 3
postmenopausal women (3) 3
progesterone (3) 3
protein (3) 3
quinazolines - administration & dosage (3) 3
receptor, erbb-2 - genetics (3) 3
research (3) 3
tamoxifen - therapeutic use (3) 3
therapy (3) 3
tissue array analysis (3) 3
transcriptome (3) 3
trastuzumab (3) 3
usage (3) 3
adjuvant chemotherapy (2) 2
age factors (2) 2
aged, 80 and over (2) 2
amplification (2) 2
antibodies, monoclonal - pharmacology (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - pharmacology (2) 2
antitumor-activity (2) 2
apoptosis (2) 2
aromatase inhibitors (2) 2
biomarker (2) 2
biomarkers, tumor - analysis (2) 2
breast cytology (2) 2
cancer therapies (2) 2
carcinoma - metabolism (2) 2
cdk4/6 inhibition (2) 2
cell cycle proteins - metabolism (2) 2
cell proliferation (2) 2
clinical trials (2) 2
combination (2) 2
cyclin d (2) 2
cyclin-dependent kinase 4 (2) 2
cyclin-dependent kinase 4 - antagonists & inhibitors (2) 2
cyclin-dependent kinase 6 - antagonists & inhibitors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2011, Volume 29, Issue 2, pp. 166 - 173
Journal Article
BMC Genomics, ISSN 1471-2164, 12/2018, Volume 19, Issue 1, pp. 960 - 7
BackgroundNew single-cell isolation technologies are facilitating studies on the transcriptomics of individual cells. Bio-Rad ddSEQ is a droplet-based... 
Single-cell transcriptomics | Bioinformatics | scRNA-seq | TECHNOLOGIES | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | RNA sequencing | Usage | Transcription factors | Research | Genomics | Tools | Data processing | Genomes | Breast cancer | Source code | Ribonucleic acid--RNA | Experiments | Gene sequencing | Datasets | Demultiplexing | Software | Microfluidics
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2018, Volume 170, Issue 2, pp. 329 - 341
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 11/2014, Volume 26, Issue 6, pp. 568 - 575
Journal Article
Clinical breast cancer, ISSN 1526-8209, 06/2019
The landscape of therapeutic options for the treatment of hormone receptor (HR)-positive (HR ) HER2 breast cancer (BC) has been profoundly changed by the... 
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 07/2019, Volume 9, p. 666
The recent arrival of CDK4/6 inhibitor agents, with an approximate doubling of progression-free survival (PFS) associated with their use in hormone... 
THYMIDINE KINASE | ADVANCED BREAST-CANCER | PREDICTIVE BIOMARKER | abemaciclib | biomarker | COMBINATION | resistance | TRIAL | DEPENDENT KINASE 4/6 | THERAPY | PIK3CA | ONCOLOGY | FULVESTRANT | CDK4/6 inhibitors | DOUBLE-BLIND | thymidine kinase-1 | palbociclib | ribociclib | Care and treatment | Usage | Breast cancer | Drug resistance | Biological markers | Analysis
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2011, Volume 17, Issue 5, pp. 1147 - 1159
Journal Article
Cell, ISSN 0092-8674, 2011, Volume 144, Issue 5, pp. 703 - 718
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 42, pp. 68012 - 68022
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2012, Volume 134, Issue 2, pp. 583 - 593
Journal Article